Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount  |
|---|---|---|---|---|---|---|
| Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
| Ranbaxy USA Inc. | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
| UBS Securities Japan Co. Ltd. | UBS | financial services | price-fixing or anti-competitive practices | 2012 | DOJ_ANTITRUST | $500,000,000 |
| AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | DOJ_ANTITRUST | $500,000,000 |
| ABN AMRO Bank N.V. renamed the Royal Bank of Scotland N.V. | ABN AMRO | financial services | economic sanction violation | 2010 | DOJ_CRIMINAL | $500,000,000 |
| Google Inc. | Alphabet Inc. | information technology | off-label or unapproved promotion of medical products | 2011 | FDA | $500,000,000 |
| Science Applications International Corporation | Science Applications International Corp. (SAIC) | information technology | fraud | 2012 | USAO | $500,392,977 |
| Tenet Healthcare Corporation | Tenet Healthcare | healthcare services | False Claims Act and related | 2016 | DOJ_CIVIL | $513,000,000 |
| Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $520,000,000 |
| Airbus SE | Airbus | aerospace and military contracting | export control violation | 2020 | DOJ_CRIMINAL | $527,224,475 |
| Bank Julius Baer & Co. Ltd. | Julius Baer Group | financial services | tax violations | 2016 | DOJ_TAX | $547,000,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $550,000,000 |
| Deutsche Bank AG | Deutsche Bank | financial services | tax violations | 2010 | USAO | $553,633,153 |
| Republic New York Securities | HSBC | financial services | fraud | 2001 | USAO | $569,000,000 |
| Western Union Company | Western Union | financial services | anti-money-laundering deficiencies | 2017 | DOJ_CRIMINAL | $586,000,000 |
| Indivior Solutions | Indivior PLC | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
| Prudential Equity Group LLC | Prudential Financial | financial services | investor protection violation | 2006 | DOJ_CRIMINAL | $600,000,000 |
| Abbott Laboratories and CG Nutritionals | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $600,000,000 |
| Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | USAO | $600,000,000 |
| Boeing Company | Boeing | aerospace and military contracting | False Claims Act and related | 2006 | DOJ_CIVIL | $615,000,000 |
| Bank Hapoalim B.M. and Bank Hapoalim (Switzerland) Ltd. | Bank Hapoalim | financial services | tax violations | 2020 | DOJ_TAX | $616,910,000 |
| ING Bank N.V. | ING | financial services | economic sanction violation | 2012 | DOJ_CRIMINAL | $619,000,000 |
| British American Tobacco | British American Tobacco | tobacco | economic sanction violation | 2023 | DOJ_NATSEC | $629,000,000 |
| Commerzbank AG | Commerzbank | financial services | economic sanction violation | 2015 | DOJ_CRIMINAL | $642,000,000 |
| Olympus Corp. of the Americas | Olympus | electrical and electronic equipment | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $646,000,000 |
| Gunvor S.A. | Foreign Corrupt Practices Act | 2024 | DOJ_CRIMINAL | $661,698,515 | ||
| Serono, S.A. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $704,000,000 |
| Barclays PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $710,000,000 |
| Adelphia Communications Corporation | accounting fraud or deficiencies | 2005 | DOJ_CRIMINAL | $715,000,000 | ||
| Societe Generale S.A. | Societe Generale | financial services | economic sanction violation | 2018 | USAO | $717,200,000 |
| SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
| Mobile TeleSystems PJSC | Mobile TeleSystems PJSC | telecommunications | Foreign Corrupt Practices Act | 2019 | DOJ_CRIMINAL | $750,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Alstom S.A. | Alstom | miscellaneous energy products and systems | Foreign Corrupt Practices Act | 2015 | DOJ_CRIMINAL | $772,290,000 |
| Deutsche Bank AG | Deutsche Bank | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $775,000,000 |
| Lafarge S.A. | Holcim Group | building materials | payment to designated terrorist organization | 2022 | USAO | $777,780,000 |
| UBS AG | UBS | financial services | tax violations | 2009 | DOJ_TAX | $780,000,000 |
| HCA-The Healthcare Company | HCA Healthcare | healthcare services | False Claims Act and related | 2000 | DOJ_CIVIL | $840,000,000 |
| Societe Generale S.A. | Societe Generale | financial services | Foreign Corrupt Practices Act | 2018 | DOJ_CRIMINAL | $860,000,000 |
| TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
| General Motors | General Motors | motor vehicles | motor vehicle safety violation | 2015 | NHTSA | $900,000,000 |
| JPMorgan Chase & Co. | JPMorgan Chase | financial services | fraud | 2020 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $920,000,000 |
| Citicorp | Citigroup | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $925,000,000 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| Takata Corporation | Ningbo Joyson Electronic | automotive parts | fraud | 2017 | DOJ_CRIMINAL | $1,000,000,000 |
| Glencore International A.G. and Glencore Ltd. | Glencore | financial services | Foreign Corrupt Practices Act | 2022 | DOJ_CRIMINAL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,185,000,000 |
| Toyota Motor Corporation | Toyota | motor vehicles | motor vehicle safety violation | 2014 | NHTSA | $1,200,000,000 |
| HSBC Holdings plc HSBC Bank USA N.A. | HSBC | financial services | anti-money-laundering deficiencies | 2012 | DOJ_CRIMINAL | $1,256,000,000 |
| Reckitt Benckiser Group plc | Reckitt Benckiser | household and personal care products | Controlled Substances Act violation | 2019 | USAO | $1,347,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| JPMorgan Chase Bank | JPMorgan Chase | financial services | anti-money-laundering deficiencies | 2014 | USAO | $1,700,000,000 |
| SAC Capital | insider trading | 2013 | USAO | $1,800,000,000 | ||
| Credit Suisse AG | UBS | financial services | tax violations | 2014 | DOJ_TAX | $1,800,000,000 |
| Danske Bank A/S | Danske Bank | financial services | anti-money-laundering deficiencies | 2022 | DOJ_CRIMINAL | $2,000,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
| BNP Paribas S.A. | BNP Paribas | financial services | economic sanction violation | 2014 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,243,400,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| Boeing Company | Boeing | aerospace and military contracting | fraud | 2021 | DOJ_CRIMINAL | $2,513,600,000 |
| Goldman Sachs Group Inc. | Goldman Sachs | financial services | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $2,921,088,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
| Wells Fargo & Company | Wells Fargo | financial services | fraud | 2020 | DOJ_CIVIL | $3,000,000,000 |
| BP Exploration and Production Inc. | BP | oil and gas | oil spill | 2012 | DOJ | $4,000,000,000 |
| Volkswagen | Volkswagen | motor vehicles | air pollution violation | 2017 | EPA | $4,300,000,000 |
| Binance Holdings Limited | Binance Holdings | financial services | anti-money-laundering deficiencies | 2023 | DOJ_NATSEC | $4,316,126,163 |
| Allianz Global Investors U.S. LLC | Allianz | financial services | investor protection violation | 2022 | USAO | $5,763,000,000 |
| Purdue Pharma LP | Purdue Pharma | pharmaceuticals | fraud | 2020 | DOJ_CIVIL | $8,344,000,000 |
| BNP Paribas S.A. | BNP Paribas | financial services | economic sanction violation | 2015 | DOJ_CRIMINAL | $8,973,600,000 |
